Odyssey Health, Inc. income statement ODYY

Annual Quarterly

It recorded a net loss of $5.7 million. Diluted earnings per share were -$0.05.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line	FY 2026 Jul 31, 2026	FY 2025 Jul 31, 2025	FY 2024 Jul 31, 2024	FY 2023 Jul 31, 2023	FY 2022 Jul 31, 2022	FY 2021 Jul 31, 2021	FY 2021 Jul 31, 2020	FY 2019 Jul 31, 2019	FY 2018 Jul 31, 2018	FY 2017 Jul 31, 2017
Revenue	—	—	—	—	—	—	0	0	0	0 -100.0%
Cost of revenue	—	—	—	—	—	—	0	0	0	0 -100.0%
Gross profit	—	—	—	—	—	—	0	0	0	0 -100.0%
Research and development	0 -100.0%	0	—	—	—	2	0	—	—	—
Selling, general and administrative	1 -10.6%	1 -51.0%	2 -1.8%	2 -27.3%	3 -24.1%	5	4	23 +7982.7%	0 +72.5%	0 +84.7%
Operating income	-1 +10.6%	-1 +52.3%	-2 +59.7%	-5 +34.4%	-8 -110.7%	-16	-4	-24 -5508.1%	-0 -150.9%	-0 -127.8%
Income tax	0	0	0	0	0	0	0	—	—	—
Net income	-6 -228.8%	-2 -106.9%	-1 +85.8%	-6 +29.9%	-8 -94.2%	-17	-4	-23 -4749.6%	-0 -144.2%	-0 -129.7%
Basic EPS	-0.05 -150.0%	-0.02 -100.0%	-0.01 +85.7%	-0.07 +22.2%	-0.09 -80.0%	-0.18	-0.05	-0.34	0.00	0.00
Diluted EPS	-0.05 -150.0%	-0.02 -100.0%	-0.01 +85.7%	-0.07 +22.2%	-0.09	—	—	—	—	—
Weighted average shares, basic	108 +3.5%	105 +7.9%	97 +17.4%	83 -7.1%	89 +2.1%	94	87	70 -40.3%	117 +2.0%	115 +0.0%
Weighted average shares, diluted	108 +3.5%	105 +7.9%	97 +17.4%	83 -7.1%	89	—	—	—	—	—
Other measures
Depreciation and amortization	—	—	0 -55.0%	0	—	0	0	0 +0.0%	0 -0.0%	0 +105.4%
EBITDA	—	—	-2 +59.7%	-5	—	-16	-4	-24 -5649.9%	-0 -161.0%	-0 -129.5%
Interest coverage	-0.58x	-4.04x	-4.13x	—	—	—	—	—	—	—

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as: ODYY (OTC)
Fiscal year ends: July 31
Incorporated in: NV
Headquarters: Las Vegas, NV
SEC filer status: Non-accelerated filer, Smaller reporting company
SEC CIK: 1626644
Former names: Odyssey Group International, Inc. (until Feb 18, 2022)

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.